Arecor Therapeutics plc (AIM:AREC)
London · Delayed Price · Currency is GBP · Price in GBX 59.50
0.00 (0.00%)
Aug 14, 2026, 2:42 PM GMT
Arecor Therapeutics Market Cap
Arecor Therapeutics has a market cap or net worth of 22.47 million as of August 14, 2026. Its market cap has decreased by -5.56% in one year.
Market Cap
22.47M
Enterprise Value
16.43M
Revenue
1.71M
Ranking
n/a
PE Ratio
29.75
Stock Price
59.50
ChartMarket Cap Chart
Since June 3, 2021, Arecor Therapeutics's market cap has decreased from 66.99M to 22.47M, a decrease of -66.47%. That is a compound annual growth rate of -18.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 22.47M | -26.09% |
| Dec 31, 2025 | 30.39M | 9.52% |
| Dec 31, 2024 | 27.75M | -50.35% |
| Dec 29, 2023 | 55.89M | -23.94% |
| Dec 30, 2022 | 73.48M | -34.00% |
| Dec 31, 2021 | 111.34M | 66.19% |
| Jun 3, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| hVIVO | 46.03M |
| Hemogenyx Pharmaceuticals | 42.16M |
| Sareum Holdings | 35.33M |
| SkinBioTherapeutics | 26.56M |
| ImmuPharma | 25.58M |
| IXICO | 16.35M |
| Aptamer Group | 14.68M |
| Palatin Technologies | 13.96M |